Inherited and inducible chromosomal instability: A fragile bridge between genome integrity mechanisms and tumourigenesis

Journal of Pathology

Volumn 187, Issue 1, 1999, Pages 19-27

  Wright, Eric G ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Chromosomal instability; Ionizing radiation; Leukaemia lymphoma

Indexed keywords

ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CANCER; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME ABERRATION; EVOLUTION; FANCONI ANEMIA; GENE MUTATION; GENETIC PREDISPOSITION; GENOME; IONIZING RADIATION; LEUKEMIA; LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HEMATOLOGIC NEOPLASMS; HUMANS; MICE; RADIATION INJURIES;

EID: 0032907251     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199901)187:1<19::AID-PATH233>3.0.CO;2-1     Document Type: Review

References (109)

1. Meyn MS. Chromosome instability syndromes; lessons for carcinogenesis. In: Kastan MB, ed. Genetic Instability and Tumorigenesis. Berlin: Springer-Verlag, 1997; 71-148.
2. Buchwald M, Moustacchi E. Is Fanconi anemia caused by a defect in the processing of DNA damage? Mutat Res 1998; 408: 75-90.
3. Rotman G, Shiloh Y. The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. Cancer Surv 1997; 29: 285-304.
4. Watt PM, Hickson ID. Genome stability: failure to unwind causes cancer. Curr Biol 1996; 6: 225-267.
5. German J, Archibald R, Bloom D. Chromosomal breakage in a rare and probably genetically determined syndrome of man. Science 1965; 148: 506-507.
6. Cohen MM, Levy HP. Chromosome instability syndromes. Adv Hum Genet 1469; 18: 43-149.
7. Cole J, Skopek TR. Somatic mutation frequency, mutation rates and mulational spectra in the human population in vivo. Mutat Res 1994; 304: 13-105.
8. Costa ND, Thacker J. Response of radiation-sensitive human cells to defined DNA breaks. Int J Radiat Biol 1993; 64: 523-529.
9. Ellis NA, Groden J, Ye T-Z, et al. The Bloom's syndrome gene product is homologous to recQ helicases. Cell 1995; 57: 1019-1027.
10. Harnden DG. The nature of ataxia-telangiectasia: problems and perspectives. Int J Radiat Biol 1994; 66: S13-S19.
11. Shiloh Y. Ataxiu-telangiectasia: closer to unravelling the mystery. Eur J Hum Genet 1995; 3: 116-138.
12. Taylor M. Ataxia-telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer. Br J Cancer 1992; 66: 5-9.
13. Reed WB, Epstein WL, Boder E, Sedgwick S. Cutaneous manifestations of ataxia-telangiectasia. J Am Med Assoc 1966; 195: 746-753.
14. Swift M, Reitnauer PJ, Morrel D, Chase CL. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 1289-1294.
15. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 1991; 325: 1831-1836.
16. Easton DF. Cancer risks in A-T heterozygotes. Int J Radiat Biol 1994; 66: S177-S182.
17. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia-telangiectasia gene product with a product similar to PI-3 kinase. Science 1995; 268: 1749-1753.
18. Hecht F, McCavv BK, Rigas DA, et al. Leukaemia and lymphoma in ataxia-telangiectasia. Lancet 1966; 2: 1193.
19. Kojis TL, Gatti RA, Sparks RS. The cytogenetics of ataxia-telangiectasia. Cancer Genet Cytogenet 1991; 56: 143-156.
20. Taylor AMR, Oxford JM, Metcalf JA. Spontaneous cytogenetic abnormalities in lymphocytes from 13 patients with ataxia-telangiectasia. Int J Cancer 1981; 27: 311-319.
21. Aurias A, Dutrillaux B, Buriot D, Lejeune J. High frequencies of inversions and translocations of chromosome 7 and 14 in ataxia-telangiectasia. Mutat Res 1980; 69: 369-374.
22. Bigbee WL, Lunglois RG, Swift M. Jensen RH Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia-telangiectasia. Am J Hum Genet 1989; 44: 402-408.
23. Cole J, Arlett CF. Cloning efficiency and spontaneous mutation frequency in circulating T-lymphocytes in ataxia-telangiectasia patients. Int J Radiat Biol 1994; 66: S123-S131.
24. Gotoff SP, Amirmokri E, Liebner EJ. Neoplasia, untoward response to X-irradiation and tuberous sclerosis. Am J Dis Child 1967; 114: 617-625.
25. Thacker J Cellular radiosensitivity in ataxia-telangiectasia. Int J Radiat Biol 1994; 66: S87-S94.
26. Taylor AMR, Harnden DG, Arlett CF, et al. Ataxia-telangiectasia: a human mutation with abnormal radiosensitivity. Nature 1975; 158: 544-547.
27. Painter RB, Young BR. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci USA 1980; 77: 7215-7217.
28. Kastan MB, Zhan Q, el-Deiry WS, et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587-597.
29. Khanna KK, Lavin MF. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 1993; 8: 3307-3312.
30. Canman CE, Wolff AC, Chen CY, Fornace AJ Jr, Kastan MB. The p53-dependent G1 cell cycle checkpoint pathway and axia-telangiectasia. Cancer Res 1994; 54: 5054-5058.
31. Carpenter CL, Cantley LC. Phosphoinositide kinases. Curr Opin Cell Biol 1996; 8: 153-158.
32. Cohen MM, Shaham M, Dagan J, Shmueli E, Kohn G. Cytogenetic investigations in families with ataxia-telangiectasia. Cytogenet Cell Genet 1975; 15: 338-356.
33. Oxford JM, Harnden DG, Parrington JM, Delhanty JD. Specific chromosome aberrations in ataxia-telangiectasia. J Med Genet 1975; 12: 251-262.
34. Natarajan AT, Meijers M, van Zeeland AA, Simons JW. Attempts to detect ataxia-telangiectasia (AT) heterozygotes by cytogenetical techniques. Cytogenet Cell Genet 1982; 33: 145-151.
35. Nagasawa H, Latt SA, Lalande ME, Little JB. Effects of X-irradiation on cell cycle progression, induction of chromosomal aberrations and cell killing in ataxia-telangiectasia (AT) fibroblasts. Mutat Res 1985; 148: 71-82.
36. Scott D, Spreadborough AR, Roberts SA, Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes. Int J Radiat Biol 1994; 66: S157-S163.
37. Lavin MF, Bennett I, Ramsay J, et al. Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 1994; 86: 1627-1634.
38. Jones LA, Scoll D, Cowan R, Roberts SA. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol 1995; 67: 519-528.
39. Ramsay J, Birrell G. Normal tissue radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys 1995; 31: 339-344.
40. Blocher D, Sigut D, Hannan MA. Fibroblasts from ataxia-telangiectasia (AT) and AT heterozygotes show an enhanced level of residual DNA double-strand breaks after low dose-rate gamma-irradiation as assayed by pulsed field gel electrophoresis. Int J Radiat Biol 1991; 60: 791-802.
41. Alter BP. Clinical features of Fanconi's anemia. In: Young NS. Alter BP, eds. Aplastic Anemia: Acquired and Inherited. Philadelphia: W. B. Saunders, 1994; 271-274.
42. Auerbach AD, Fanconi anemia. Dermatol Clin 1995; 13: 41-49.
43. Joenje H, Oostra AB, Wijker M, et al. Evidence for at least eight Fanconi anemia genes. Am J Hum Genet 1997; 61: 940-944.
44. Schroder TM. Genetically determined chromosomal breakage and high incidence of leukemia in inherited disease. Blood 1982; 37: 96-112.
45. Alter BP, Scalise A, McCombs J, Najfeld V. Clonal chromosomal abnormalities in Fanconi's anaemia: what do they really mean? Br J Haematol 1993; 85: 627-630.
46. Joenje H, Arwert F, Eriksson AW, De Koning H, Oostra AB. Oxygen-dependence of chromosomal aberrations in Fanconi's anemia. Nature 1981; 290: 142-143.
47. Alter BP. Pathophysiology of Fanconi's anemia. In: Young NS, Alter BP, eds. Aplastic Anemia: Acquired and Inherited. Philadelphia: W. B. Saunders, 1994; 310-324.
48. Degan P, Bonassi S, De Caterina M, et al. In vivo accumulation of 8-hydroxy-2′-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anemia families. Carcinogenesis 1995; 16: 735-741.
49. 2 as determined by alkaline elution. Biochim Biophys Acta 1982; 698: 237-242.
50. Bigbee WL, Jensen RH, Grant SG, Langlois RG, Olsen DA, Auerbach AD. Evidence for elevated in vivo somatic mutation at the glycophorin A locus in Fanconi anemia. Am J Hum Genet 1989; 49 (Suppl): 446.
51. Vijayalakshmi E, Wunder P, Schroeder TM. Spontaneous 6-thioguanine-resistant lymphocytes in Fanconi anemia patients and their heterozygous parents. Hum Genet 1985; 70: 261-270.
52. Dutrillaux B, Aurias A, Dutrillaux AM, Buriot D, Prieur M. The cell cycle of lymphocytes in Fanconi anemia. Hum Genet 1982; 62: 327-332.
53. Kubbies M, Schindler D, Hoehn H, Schinzel A, Rabinovich PS. Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent endomitosis in Fanconi anemia cells. Am J Hum Genet 1985; 37: 1022-1027.
54. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA. Flow cytometric characterization of the response of Fanconi anemia cells to mitomycin C treatment. Cytometry 1982; 2: 291-297.
55. Seyschab H, Bretzel G, Friedl R, Schindler D, Sun Y, Hoehn H. Modulation of the spontaneous G2 phase blockage in Fanconi anemia cells by caffeine. Differences from cells arrested by X-irradiation. Mutat Res 1994; 308: 149-157.
56. Roselli F, Ridet A, Soussi T, Duchaud E, Alapetite C, Moustacchi E. P53-dependent pathways of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 1995; 10: 9-17.
57. Roselli F, Sanceau J, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet 1992; 89: 42-48.
58. Roselli F, Sanceau J, Gluckman E, Wietzerbin J, Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumour necrosis factor alpha. Blood 1994; 83: 1216-1225.
59. Schultz JC, Shahidi NT. Tumour necrosis factor-alpha overproduction in Fanconi's anemia. Am J Hematol 1993; 42: 196-201.
60. Graham GJ, Wright EG. Haemopoietic stem cells; their heterogeneity and regulation. Int J Exp Pathol 1997; 78: 197-218.
61. Zhang Y, Harada A, Bluethmann H, Wang JB, Nakao S, Matsuchima K. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increases of early hematopoietic progenitor cells in TNF receptor-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995; 86: 2930-2937.
62. Maciejewski JP, Selleri C, Sato T, Anderson S, Young NS. Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 1995; 91: 245-252.
63. Pedahl EB, Naprstek BL, Wallace WC, Lipton JM. Erythroid failure in Diamond-Blackfan anemia is characterised by apoptosis. Blood 1994; 83: 645-650.
64. Strathdee CA, Gavish H, Shannon WR, Buchwald M, Cloning of cDNAs for Fanconi's anemia by functional complementation. Nature 1992; 356: 763-767.
65. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi's anemia gene, FAA. Nature Genet 1996; 14: 320-323.
66. Fanconi Anemia/Breast Cancer Consortium. Positional cloning of the Fantoni anemia group A gene. Nature Genet 1996; 14: 324-328.
67. Youssoufian H. Localization of Fanconi anemia complementation group C protein to the cytoplasm of mammalian cells. Proc Natl Acad Sci USA 1994; 91: 7975-7979.
68. Yamashita T, Barker DL, Zhu Y, Wu N, D-Andrea AD. The Fantoni anemia polypeptide FACC is localized to the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 6712-6716.
69. Youssoufian H, Auerbath AD, Verlander PC, Steimle V, Mach B. Identification of cytosolic proteins that hind to the Fanconi anemia complementation group C polypeptide in vitro. J Biol Chem 1995; 270: 9876-9882.
70. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anemia proteins. FAA and FAC, interact to form a nuclear complex. Nature Genet 1997; 17: 487-490.
71. Kupfer GM, Yamashita T, Naf D, Suliman S, Asano S, D'Andrea AD. The Fanconi anemia polypeptide, FAC. binds to the cyclin-dependent kinase cdc2. Blood 1997; 90: 1047-1054.
72. Little JB, Gorgojo L, Vetros H. Delayed appearance of lethal and specific gene mutations in irradiated mammalian cells. Int J Radiat Oncol Biol Phys 1990; 19: 1425-1429.
73. Chang WP, Little JB. Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving X irradiation: association with delayed reproductive death phenotype. Mutat Res 1992; 270: 191-199.
74. Harper K, Lorimore SA, Wright EG. Delayed appearance of radiation-induced mutations at the Hprt locus in murine haemopoietic cells. Exp Hematol 1997; 25: 263-269.
75. Pampfer S, Streffer C. Increased chromosome aberration levels in cells from mouse fetuses after zygote X-irradiation. Int J Radiat Biol 1989; 55: 85-92.
76. Kadhim MA, Macdonald DA, Goodhead DT, Lorimore SA, Marsden SJ, Wright EG. Transmission of chromosomal instability after plutonium α-particle irradiation. Nature 1992; 355: 738-740.
77. Kadhim MA, Lorimore SA, Hepburn MD, Goodhead DT, Buckle VJ, Wright EG. Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet 1994; 344: 987-988.
78. Kadhim MA, Lorimore SA, Townsend KMS, Goodhead DT, Buckle VJ, Wright EG. Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells. Int J Radiat Biol 1995; 67: 287-293.
79. Kadhim MA, Marsden SJ, Wright EG. Radiation-induced chromosomal instability in human fibroblasls: temporal effects and the influence of radiation quality. Int J Radiat Biol 1988; 73: 143-148.
80. Martins MB, Sabatier L, Ricoul M, Pinion A, Dutrillaux B. Specific chromosome instability induced by heavy ions: a step towards transformation of human fibroblasts. Mutat Res 1993; 285: 229-237.
81. Holmberg K, Falt S, Johansson A, Lambert B. Chromosome aberrations and genomic instability in X-irradiated human T-lymphocyte cultures. Mutat Res 1993; 286: 321-330.
82. Holmberg K, Meijer AE, Auer G, Lambert B. Delayed chromosomal instability in human T-lymphocyte clones exposed to ionizing radiation. Int J Radiat Biol 1995; 68: 245-255.
83. Marder BA, Morgan WF. Delayed chromosomal instability induced by DNA damage. Mol Cell Biol 1993; 13: 6667-6677.
84. Durante M, Grossi GF, Yang TC. Radiation-induced chromosomal instability in human mammary epithelial cells. Adv Space Res 1996; 18: 99-108.
85. Ponnaiya B, Cornforth MN, Ullrich RL. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice. The difference is as clear as black and white. Radial Res 1997; 147: 121-125.
86. Ponnaiya B, Cornforth MN, Ullrich RL. Induction of chromosomal instability in human mammary cells by neutrons and gamma rays. Radiat Res 1997; 147: 288-294.
87. Lorimore SA, Goodhead DT, Wright EG. Inactivation of haemopoietic stem cells by slow alpha-particles. Int J Radiat Biol 1993; 63: 655-660.
88. Watson GE, Lorimore SA, Clinton SM, Kadhim MA, Wright EG. Genetic factors influencing alpha-particle-induced chromosomal instability. Int J Radiat Biol 1997; 71: 497-503.
89. Watson GE, Lorimore SA, Wright EG. Long-term in vivo transmission of alpha-particle-induced chromosomal instability in murine haemopoietic cells. Int J Radiat Biol 1996; 69: 175-182.
90. Little JB, Nagasawa H, Pfenning T, Vetrovs H. Radiation-induced genomic instability: delayed mutations and cytogenetic effects of X-rays and alpha-particles. Radiat Res 1997; 148: 299-307.
91. Li C-Y, Yandell DW, Little JB. Evidence for coincident mutations in human lymphoblast clones selected for functional loss of a thymidine kinase gene. Mol Carcinogenesis 1992; 5: 270-277.
92. Li C-Y, Yandell DW, Little JB. Elevated frequency of microsatellite mutations in TK6 human lymphoblast clones selected for mutations at the thymidine kinase locus. Mol Cell Biol 1994; 14: 4373-4379.
93. Grosovsky AJ, Parks KK, Give CR, Nelson SL. Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol Cell Biol 1996; 16: 6252-6262.
94. Limoli CL, Kaplan MI, Phillips JW, Adair GM, Morgan WF. Differential induction of chromosomal instability by DNA strand-breaking agents. Cancer Res 1997; 57: 4048-4056.
95. Clutton SM, Townsend KMS, Walker C, Ansell JD, Wright EG. Radiation-induced genomic instability and persisting oxidative stress in bone marrow cultures. Carcinogenesis 1996; 17: 1633-1639.
96. Emerit I. Reactive oxygen species, chromosome mutation and cancer: possible role of clastogenic factors in carcinogenesis. Free Radicals Biol Med 1994; 16: 99-109.
97. Duell T, Lengfelder E, Fink R, Giesen R, Bauchinger M. Effect of activated oxygen species in human lymphocytes. Mutat Res 1995; 336: 29-38.
98. Lorimore SA, Kadhim MA, Pocock DA, et al. Chromosomal instability in the descendants of unirradiated surviving cells after α-particle irradiation. Proc Natl Acad Sci USA 1998; 95: 5730-5733.
99. Nagasawa H, Little JB. Induction of sister chromatid exchanges by extremely low doses of α-particles. Cancer Res 1992; 52: 6394-6396.
100. Hickman AW, Jaramillo RJ, Leehner JE, Johnson NE. α-particle-induced p53 protein expression in a rat lung epithelial cell strain. Cancer Res 1994; 54: 5797-5800.
101. Deshpande A, Goodwin EH, Bailey SM, Marrone BL, Lehnert BE. Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: evidence for an extra-nuclear target. Radiat Res 1996; 145: 260-267.
102. Manti L, Jamali M, Prise KM, Michael BD, Trott K-R. Genomic instability in Chinese hamster cells after exposure to X-rays or alpha-particles of different mean linear energy transfer. Radiat Res 1997; 147: 2-28.
103. Weitzman SA, Stossel TP. Mutation caused by human phagocytes. Science 1981; 212: 546-547.
104. Dizdaroglu M, Olinski R, Doroshow JH, Akam SA, Modification of DNA bases in chromatin of intact target human cells by activated human polymorphonuclear leukocytes. Cancer Res 1993; 53: 1269-1272.
105. Birnboim HC. DNA strand breakage in human leukocytes exposed to a tumour promoter, phorbol myristate acetate. Science 1982; 215: 1247-1249.
106. Schacter E, Beecham EJ, Covet JM, Kohn KW, Potter M. Activated neutrophils induce prolonged DNA damage in neighbouring cells. Carcinogenesis 1988; 9: 2297-2304.
107. Weitberg AB, Wenzman SA, Destrempes M, Latt SA, Stossel TP. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med 1983; 308: 26-30.
108. Weitzman SA, Weitberg AB, Clark EP, Stossel TP. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985; 227: 1231-1233.
109. Weitzman SA, Gordon LI. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood 1990; 76: 655-663.